Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents
Crossref DOI link: https://doi.org/10.1007/s11523-015-0362-0
Published Online: 2015-03-11
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
García-Alfonso, Pilar
Ferrer, Ana
Gil, Silvia
Dueñas, Rosario
Pérez, María Teresa
Molina, Raquel
Capdevila, Jaume
Safont, María José
Castañón, Carmen
Cano, Juana María
Lara, Ricardo
License valid from 2015-03-11